Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
Pallesen, J., Wang, N., Corbett, K.S., Wrapp, D., Kirchdoerfer, R.N., Turner, H.L., Cottrell, C.A., Becker, M.M., Wang, L., Shi, W., Kong, W.P., Andres, E.L., Kettenbach, A.N., Denison, M.R., Chappell, J.D., Graham, B.S., Ward, A.B., McLellan, J.S.(2017) Proc. Natl. Acad. Sci. U.S.A. 114: E7348-E7357
- PubMed: 28807998 
- DOI: 10.1073/pnas.1707304114
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus that since its emergence in 2012 has caused outbreaks in human populations with case-fatality rates of ∼36%. As in other coronaviruses, the spike (S) glycoprotein ...